Use the new 2019 eCQM (EHR) Measure help files to view specifications and workflow information for the following measures:
- CMS 2v8: Preventive Care and Screening: Screening for Clinical Depression and Followup Plan
- CMS 22v7: Screening for High Blood Pressure and Follow-up Documented
- CMS 50v7: Closing the Referral Loop: Receipt of Specialist Report
- CMS 52v7: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
- CMS 56v7: Functional Status Assessment for Total Hip Replacement
- CMS 66v7: Functional Status Assessment for Total Knee Replacement
- CMS 68v8: Documentation of Current Medications in the Medical Record
- CMS 69v7: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Plan
- CMS 74v8: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
- CMS 75v7: Children Who Have Dental Decay or Cavities
- CMS 82v6: Maternal Depression Screening
- CMS 90v8: Functional Status Assessments for Congestive Heart Failure
- CMS 117v7: Childhood Immunization Status
- CMS 122v7: Diabetes Hemoglobin A1c (HbA1c) Poor Control (>9%)
- CMS 124v7: Cervical Cancer Screening
- CMS 125v7: Breast Cancer Screening
- CMS 127v7: Pneumococcal Vaccination Status for Older Adults
- CMS 128v7: Anti-Depressant Medication Management
- CMS 129v8: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
- CMS 130v7: Colorectal Cancer Screening
- CMS 131v7: Diabetes: Eye Exam
- CMS 132v7: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
- CMS 133v7: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
- CMS 134v7: Diabetes: Medical Attention for Nephropathy
- CMS 135v7: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- CMS 136v8: Follow-up Care for Children Prescribed ADHD Medication (ADD)
- CMS 137v7: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
- CMS 138v7: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
- CMS 139v7: Falls: Screening for Future Fall Risk
- CMS 142v7: Diabetic Retinopathy Communication with the Physician Managing Ongoing Diabetes Care
- CMS 143v7: Primary Open-angle Glaucoma (POAG): Optic Nerve Evaluation
- CMS 144v7: Heart Failure (HF) Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
- CMS 145v7: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
- CMS 146v7: Appropriate Testing for Children with Pharyngitis
- CMS 147v8: Preventive Care and Screening: Influenza Immunization
- CMS 149v7: Dementia: Cognitive Assessment
- CMS 153v7: Chlamydia Screening for Women
- CMS 154v7: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
- CMS 155v7: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
- CMS 156v7: Use of High-Risk Medications in the Elderly
- CMS 157v7: Oncology: Medical and Radiation – Pain Intensity Quantified
- CMS 159v7: Depression Remission at Twelve Months
- CMS 160v7: Depression Utilization of the PHQ-9 Tool
- CMS 161v7: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
- CMS 165v7: Controlling High Blood Pressure
- CMS 177v7: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
- CMS 347v2: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
- CMS 645v2: Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
